Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Dabur India Ltd dropped for a fifth straight session today. The stock is quoting at Rs 384.05, down 0.56% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.07% on the day, quoting at 24107.55. The Sensex is at 77076.65, up 0.19%.Dabur India Ltd has eased around 11.45% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 6.06% in last one month and is currently quoting at 47030.45, down 0.74% on the day. The volume in the stock stood at 8.39 lakh shares today, compared to the daily average of 19.87 lakh shares in last one month.
The benchmark September futures contract for the stock is quoting at Rs 386.35, down 0.89% on the day. Dabur India Ltd tumbled 26.3% in last one year as compared to a 1.31% slide in NIFTY and a 16.85% fall in the Nifty FMCG index.
The PE of the stock is 44.26 based on TTM earnings ending June 26.
Dabur India Ltd fell for a fifth straight session today. The stock is quoting at Rs 428, down 0.34% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.83% on the day, quoting at 24273.6. The Sensex is at 77983.71, up 1.03%.Dabur India Ltd has eased around 0.16% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 1.99% in last one month and is currently quoting at 48408, up 0.53% on the day. The volume in the stock stood at 11.47 lakh shares today, compared to the daily average of 21.6 lakh shares in last one month.
The benchmark July futures contract for the stock is quoting at Rs 428.8, up 0.75% on the day. Dabur India Ltd tumbled 18.1% in last one year as compared to a 2.78% slide in NIFTY and a 13.88% fall in the Nifty FMCG index.
The PE of the stock is 51.06 based on TTM earnings ending March 26.
The company said its India FMCG business maintained growth momentum during the quarter, with rural demand continuing to outpace urban markets. It expects the domestic FMCG business to post near double-digit growth.
The Home and Personal Care business is expected to grow at a near-teen rate. Hair oils and shampoos are likely to deliver high-teen growth, while oral care is expected to post near double-digit growth. Dabur said brands including the Herbal franchise, Meswak, Red Toothpaste and Lal Dant Manjan recorded broad-based growth.
The healthcare business is expected to record mid-single-digit growth with sequential improvement. Flagship brands such as Hajmola, Pudin Hara, the Health Juices range, Dabur Honitus and Isabgol are expected to post robust double-digit growth. Dabur Glucose also recovered sequentially after being impacted during the early part of the quarter.
The food business continued to record high double-digit growth, led by Badshah, while the beverage portfolio recovered sequentially on the back of strong growth in the Real Activ Juices range and Coconut Water. Emerging channels, including e-commerce, quick commerce and modern trade, are expected to post strong double-digit growth. Rural markets continued to outperform urban markets.
Dabur's international business is expected to post high-teen growth in rupee terms despite headwinds in the Middle East. Markets including Egypt, Turkey, Bangladesh and the UK recorded strong double-digit growth.
The company said elevated inflation, particularly in the haircare segment, was mitigated through calibrated price increases, helping maintain stable operating margins. It added that the business fundamentals remain strong and it remains focused on improving consumption, enhancing cost competitiveness, strengthening digital capabilities and delivering sustainable, profitable growth over the medium to long term.
Dabur India is one of India's leading FMCG companies. Its India's FMCG portfolio includes power brands like Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare space; Dabur Amla and Dabur Red Paste in the personal care category; and real in the food & beverages space.
The company reported 15.14% jump in consolidated net profit to Rs 368.60 crore on 7.35% increase in revenue from operations to Rs 3038.02 crore in Q4 FY26 over Q4 FY25.
Shares of Dabur India fell 0.60% to settle at Rs 444.05 on Friday, 3 July 2026.
Dabur India Ltd is down for a fifth straight session today. The stock is quoting at Rs 420.4, down 0.44% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is down around 0.75% on the day, quoting at 23923.15. The Sensex is at 76581.64, down 0.66%.Dabur India Ltd has lost around 5.99% in last one month.Meanwhile, Nifty FMCG index of which Dabur India Ltd is a constituent, has eased around 2.06% in last one month and is currently quoting at 49355.1, down 0.47% on the day. The volume in the stock stood at 9.53 lakh shares today, compared to the daily average of 23.44 lakh shares in last one month.
The benchmark June futures contract for the stock is quoting at Rs 421.35, down 0.55% on the day. Dabur India Ltd tumbled 11.51% in last one year as compared to a 4.48% slide in NIFTY and a 9.61% fall in the Nifty FMCG index.
The PE of the stock is 49.86 based on TTM earnings ending March 26.
The company said the US FDA had conducted an inspection at the plant and issued inspectional observations, to which it had submitted responses. Following a review of the company's responses and the Establishment Inspection Report (EIR), the regulator issued the import alert on June 10, 2026.
Dabur clarified that the order pertains only to a small section of the Silvassa manufacturing facility involved in private-label products and has no material impact on the company's financials, operations or other business activities. The affected products generate insignificant revenue for the company, it added.
The company said its domestic products are not covered by the import alert and the Silvassa plant continues to operate normally.
Dabur added that it is engaging with the US FDA through corrective and preventive action plans to address the identified gaps. The company also said multiple internal and independent third-party tests have not identified any out-of-specification issues or other concerns with its products.
The FMCG major said it is implementing alternate sourcing strategies for its US customers while continuing to focus on product quality and consumer safety.
Dabur India is one of India's leading FMCG companies. The company manufactures personal care, healthcare and food products. Its portfolio includes eight major power brands- Dabur Chyawanprash, Dabur Honey, Honitus, PudinHara and Dabur Lal Tail in the healthcare catrogory, Dabur Amla and Dabur Red Paste in the personal care and Real in the food & beverages space.
Shares of Dabur India rose 0.44% to Rs 424.05 on the BSE.